Main obstetric manifestations related to APS associated with SLE and primary APS that appeared during the 10-year follow-up (1999–2009) of the ‘Euro-Phospholipid’ cohort
| Obstetric manifestations | APS associated with SLE (n=14)* No. (%) | Primary APS (n=65)* No. (%) | p Value† |
|---|---|---|---|
| Pre-eclampsia/eclampsia‡ | 1 (7.1) | 3 (4.6) | |
| Early pregnancy loss (<10 weeks)‡ | 3 (21.4) | 10 (15.3) | |
| Late pregnancy loss (≥10 weeks)‡ | 0 | 2 (2.4) | |
| Live birth‡ | 10 (71.4) | 47 (72.3) | |
| Live birth with prematurity§ | 4 (40.0) | 34 (72.3) | 0.045 |
| Live birth with intrauterine growth restriction§ | 1 (0.1) | 24 (51.1) | 0.017 |
*Number of pregnancies. Some women had more than one pregnancy.
‡Obstetric manifestation related to number of pregnancies.
†Pearson χ2.
§Fetal complications, percentage related to number of live births.
APS, antiphospholipid syndrome; SLE, systemic lupus erythematosus.